Latest Growth Opportunities News

TerraCom Limited announces the resignation of Managing Director Danny McCarthy effective 30 April 2026, with Chris Bourke appointed as interim CEO. McCarthy will support the transition until September 2026, while the Board confirms no changes to operational or strategic priorities.

Electro Optic Systems Holdings Limited (ASX: EOS) has concluded its civil penalty proceedings with ASIC, agreeing to a $4 million penalty and costs. This resolution marks a significant step in addressing legacy issues and refocusing on strategic growth.

Broken Hill Mines Limited (ASX: BHM) has reported significant production increases at its Rasp silver-lead-zinc mine for the March 2026 quarter and secured a long-term renewal of its Consolidated Mining Lease 7, extending operational rights to 2047.

Infragreen Group Limited (ASX:IFN) has launched a strategic review to explore options for enhancing shareholder value following a decline in its share price despite solid earnings growth and a positive business outlook.

PT Aneka Tambang Tbk (ANTAM) reported a historic financial year in 2025, with revenue up 22% and net profit more than doubling to Rp7.92 trillion, driven by strong domestic demand and operational efficiency. The company also navigates evolving Indonesian mining regulations and ongoing legal challenges as it invests in downstream nickel projects.

Eagers Automotive is broadening its Australian footprint through strategic investments in multi-brand dealerships and premium Audi outlets, while advancing its international ambitions with CanadaOne Auto.

AVITA Medical has lodged a new $200 million shelf registration with the SEC, renewing its capacity to issue various securities in the US market. While no immediate capital raising is planned, this move preserves the company’s financial agility for future growth opportunities.

Bioxyne Ltd has secured a manufacturing agreement with global cannabis giant Aurora Cannabis, marking a major step in its international expansion of pharmaceutical-grade medicinal cannabis products.

AVADA Group Limited has successfully refinanced its debt facilities with Commonwealth Bank of Australia, replacing a $40 million term loan with improved and more flexible financing arrangements.

Tyro Payments welcomes the Reserve Bank of Australia's reforms to merchant card payment costs, highlighting opportunities from increased transparency and competition. The changes, effective from October 2026, align with Tyro’s transparent pricing model and do not affect its near-term guidance.

Variscan Mines announces the resignation of CEO Stewart Dickson and the appointment of Tom Kent as executive director, signaling a strategic shift following the San Jose Mine Restart Study.

Atomo Diagnostics stands to gain significantly as Lumos Diagnostics’ FebriDx test secures FDA CLIA waiver approval, vastly expanding its US market potential. This regulatory milestone triggers substantial contracted revenues and prompts Atomo to ramp up production.